Methods and systems for using RFID in biological field

Information

  • Patent Grant
  • 10369573
  • Patent Number
    10,369,573
  • Date Filed
    Monday, December 12, 2016
    7 years ago
  • Date Issued
    Tuesday, August 6, 2019
    4 years ago
Abstract
Biological reagent carrier devices and methods are disclosed, which employ RFID techniques to associate information with biological reagents.
Description
INTRODUCTION

The present teaching relates to methods and systems for associating information with carriers for supporting biological reagents. During the manufacture and use of biological reagents, the reagents are typically coded and labeled in order to keep track of them. Conventional systems use bar codes to identify carriers containing reagents to be processed by analytical instrumentation. Bar codes, however, require printing and application of a bar code label to carriers for the biological reagents. At some later time the bar code is read by either a hand-held bar code scanner or by an automated bar-code scanner controlled by the instrumentation to track the reagents as they are processed.


To read a label or a barcode, however, requires an optical path to the barcode, which can be inconvenient and problematic, for example if the indicia to be read are located inside of an instrument. In the past these problems have been addressed by forming windows in the instruments or carriers to provide an optical path to the labels. Such windows can complicate the design of instruments and carriers and depending on the configuration and design of a particular window, the optical path can be distorted, resulting in optical reading and scanning problems. Further reading problems can result from printing inconsistencies and any material that covers the bar code, such as frost in a refrigerator.


Further, if information needs to be added to a label associated with a particular sample, physical access is required to print the additional information to the label. Moreover, only a limited amount of information can be printed on a label associated with a carrier due to label space limitations. When using bar codes, 1-D and 2-D bar codes are limited as to how much information can be printed in a given amount of space by the visual resolution between marks. Therefore, typically a printed carrier number or identifier is used as an index into a database of information regarding the carrier or the contents of the carrier. The database was typically provided on a separate CDROM or other removable machine-readable medium. However, it can be inconvenient to associate the information on particular CDROM with a particular carrier.


Vincogen Corporation of Trevose, Pa. purports to have filed U.S. patent application Ser. No. 10/396,269, on using RFID technology in connection with biochips to provide an identifier number for such biochips. However, the Vincogen product fails to address the above-identified deficiencies of existing methods and systems.


Accordingly, systems and methods are needed that provide for the reading from and writing to carriers for biological reagents without requiring an optical path or direct physical access to the carriers. Moreover, there is need for storing greater amounts of information than can be written on a conventional label.


SUMMARY

According to various embodiments, apparatus is provided for associating information with a biological reagent according to the present teachings. The apparatus can include a carrier for supporting the biological reagent and at least one RFID tag including a carrier RFID antenna coupled to the carrier, wherein the RFID tag is operable to be read by an RFID reader, and the RFID tag can include identification, supplemental, and/or rights information for the biological reagent.


According to various embodiments, apparatus is provided for associating information with a microarray according to the present teachings. The apparatus can include a substrate; at least one chamber coupled to the microarray; and an RFID tag having an RFID antenna coupled to the substrate.


According to various embodiments, apparatus is provided for associating information with a biological reagent according to the present teachings. The apparatus can include a carrier for the biological reagent. The carrier is coupled to an RFID tag, and the RFID tag is operable to be read by an RFID reader. The RFID tag contains identification information. Further, an instrument is provided for reading the identification information, and performing operations on the biological reagent, the instrument including an output for providing an identity indication of the biological reagent based on the identification information. The instrument is generally opaque and blocks optical paths to contents of the instrument.


According to various embodiments, the present teachings involve methods for associating information regarding biological reagents with carriers for supporting the biological reagents. A carrier for the biological reagents is provided, and the carrier is coupled to an RFID tag so that the RFID tag can be read by an RFID reader. Identification, supplemental, and/or, rights information associated with the biological reagent is received from the RFID tag.


According to various embodiments, apparatus for associating information with a biological reagent is provided. The apparatus includes a carrier for supporting the biological reagent and an RFID tag including a carrier RFID antenna coupled to the carrier. The RFID tag can be read by an RFID reader, and the RFID tag includes instrument operation information for the biological reagent.


According to various embodiments, a method for associating information regarding operations for biological reagents with carriers for supporting the biological reagents is provided. The method includes providing a carrier for at least one biological reagent, the carrier coupled to an RFID tag, which can be read by an RFID reader. The method also includes receiving, from the RFID tag, instrument operation information associated with the biological reagent.


It is understood that both the foregoing general description and the following description of various embodiments are exemplary and explanatory only and are not meant to be restrictive or to be read into the claims. The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate some embodiments, and together with the description serve to explain the principles of the embodiments described herein.





BRIEF DESCRIPTION OF THE DRAWINGS

The skilled artisan will understand that the drawings, described below, are only intended for the illustration of various embodiments. The drawings are not intended to limit the scope of the present teachings in any way.



FIG. 1 illustrates a perspective view from above a reaction plate having a plurality of reaction wells and various exemplary locations for RFID tags according to various embodiments;



FIG. 2 illustrates a perspective view from beneath a reaction plate having a plurality of reaction wells and various exemplary locations for RFID tags according to various embodiments;



FIG. 3 illustrates a tube in connection with various exemplary locations for RFID tags according to various embodiments;



FIG. 4 illustrates an embodiment of an empty tube carrier in connection with various exemplary locations for RFID tags according to various embodiments;



FIG. 5 illustrates a tube carrier containing a plurality of tubes in connection with various exemplary locations for RFID tags according to various embodiments;



FIG. 6 illustrates an exemplary embodiment of a surface plasmon resonance (SPR) array in connection with various exemplary locations for RFID tags according to various embodiments;



FIG. 7 illustrates another exemplary embodiment of a reaction plate in connection with various exemplary locations for RFID tags according to various embodiments;



FIG. 8 illustrates an exemplary embodiment of a microfluidic card in connection with various exemplary locations for RFID tags according to various embodiments;



FIG. 9 illustrates an exemplary embodiment of a microarray cartridge in connection with various exemplary locations for RFID tags according to various embodiments;



FIG. 10 illustrates an exemplary embodiment of a microarray in connection with various exemplary locations for RFID tags according to various embodiments;



FIG. 11 illustrates an exemplary embodiment of an on-line biological instrument system according to various embodiments;



FIG. 12 illustrates an exemplary embodiment of an RFID writing apparatus according to various embodiments; and



FIG. 13 illustrates an exemplary embodiment of RFID tag tracking systems according to various embodiments.





DESCRIPTION OF VARIOUS EMBODIMENTS

Reference will now be made in detail to some embodiments, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers are used throughout the drawings to refer to the same or like parts.


Radio Frequency Identification (“RFID”) provides a convenient mechanism for identifying and detecting objects using wireless electro-magnetic signals. A basic RFID system has at least one RFID reader and at least one RFID tag. Typically, RFID readers can include a coil or antenna and circuitry to transmit and receive signals with the coil or antenna. An RFID tag also includes a coil or antenna and some information that can be read by an RFID reader.


The RFID reader antenna generates an electromagnetic field, thereby transferring energy to the tag. Depending on the design of the tag, a portion of the energy transferred to the tag will be reflected to the reader so as to provide information about the tag back to the reader. Some RFID systems can be used to read and optionally write data to and from the RFID tag. RFID readers can generate signals spanning distances from less than one inch to more than 100 feet depending on frequency and power of the signals generated at the RFID reader antenna.


Typically, RFID tags are categorized as either active or passive. Active RFID tags are powered by an internal battery and are typically read/write, i.e., tag data can be rewritten and/or modified. An active tag's memory size varies according to application requirements; some systems operate with up to 1 MB of memory.


Passive RFID tags operate without a separate external power source and obtain operating power generated from the reader. Passive tags are consequently typically lighter than active tags, less expensive, and offer a long operational lifetime. Passive tags typically have shorter read ranges than active tags and require a higher-powered reader. Read-only tags are typically passive and can be programmed with a unique set of data (usually 32 to 128 bits) that is typically predetermined at the time of manufacture of the tag. It is understood that passive read/write tags can also be employed consistent with the present teachings.


The term “RFID tag” as used herein refers to either an active or passive RFID tag that contains information. The RFID tag can be read only or read/write, and the information associated with the RFID tag can be hard-coded into the RFID tag at the time of manufacture or at some later time, or the RFID tag can contain information that is written to the RFID tag throughout its lifetime.


The term “RFID reader” as used herein includes RFID devices that can read information from and/or write information into an RFID tag.


The term “carrier” as used herein refers to a structure for directly or indirectly supporting a biological reagent. Examples of carriers include reaction plates, tubes, tube carriers, surface plasmon resonance arrays, slides, conical low-volume tubes, microfluidic cards, microarray cartridges, microarrays, and other types of containers for supporting biological reagents.


The term “biological reagent” as used herein refers to a biological material used for various biological analyses such as detecting, examining, and/or measuring information from biological samples. Biological analyses can include reactions such as polymerase chain reaction (PCR), ligase chain reaction, antibody binding reaction, oligonucleotide ligation assays, and hybridization assays. Examples of biological reagents include nucleic acids, primers, probes, and other biological reagents, which can be used in performing various biological assays. “Nucleic acid” as used herein refers to nucleotides, oligonucleotides, DNA, RNA, PNA, etc. as these terms are understood by those skilled in the art of genomics.


The term “information” as used herein refers to data that can be stored electronically in the RFID tag and can be retrieved to be used as machine readable or human readable data for processing the biological reagent and/or carrier.


The term “identification information” as used herein refers to information on an RFID tag that can be used to uniquely identify a particular carrier or biological reagent or to distinguish the carrier or biological reagent from other carriers or biological reagents. For example, identification can relate a particular assay prepared for a particular customer.


The term “supplemental information” as used herein refers to descriptive information about a carrier or its contents, including certain biological reagents. Examples of supplemental information include nucleic acid sequence information and annotated information regarding experiments performed with various biological reagents.


The term “rights information” as used herein refers to authorization information for carriers or biological reagents, such as information regarding whether a particular licensee has a valid license to use a particular carrier or biological reagent, including a number of times the licensee is permitted to use the particular carrier or biological reagent in a particular assay. Rights information can also include validation information regarding whether a particular carrier or biological reagent has been subject to a recall or has otherwise become unsuitable or unauthorized for use.


The term “genealogy information” as used herein refers to information regarding the derivation of a biological reagent, including for example an identification of an original sample from which it was derived or the number of generations removed it is from an original sample.


The term “traveler information” as used herein refers to information regarding a carrier or a biological reagent contained as operations are performed on that carrier or biological reagent for example during manufacture of the biological reagent or while an assay is being performed on the biological reagent.



FIG. 1 illustrates a perspective view from above of a reaction plate 100 having a plurality of reaction wells 102 and exemplary locations 110, 112, 114, and 120 for RFID tags. It is understood that exemplary location 110 for the RFID tag, for example, can be positioned on the exterior of the reaction plate 100 in any convenient location that will permit appropriate antenna geometry and accommodate the necessary passive or active RFID circuitry necessary for proper operation of the RFID tag. For example, RFID tags 110 and 112 are shown as boxes placed in the margins of the reaction plate 110 on an upper surface 116 of the reaction plate 100. Adhesive application of an RFID tag to the surface 116 of the reaction plate 100 can advantageously permit standard consumables, such as reaction plate 100 to be manufactured and/or acquired independently from the RFID tags. Alternatively, RFID tag 120, illustrated in broken lines, can be embedded in the reaction plate 100, for example during a plastic injection molding or a blow molding manufacturing process. Trays and microcards are typically constructed of polypropylene so as to be compatible with PCR thermal cycling. Other carriers that provide transport containers as opposed to reaction containers can be made of harder plastics e.g. Lexan® (General Electric). FIG. 1 illustrates a 96-well reaction plate. As illustrated in FIG. 7, other reaction plates such as 386-well reaction plates are contemplated by the present teachings.



FIG. 2 illustrates an underside perspective view of the reaction plate 100 showing the undersides 204 of a plurality of reaction wells and at least one RFID tag 202 affixed to an underside portion of the reaction plate. As shown in FIG. 2, the RFID tags can be placed on the underside of the carrier as shown in connection with RFID tags 202 and 206, which are shown to be applied to the surface 216 of the reaction plate 100. Alternatively, an RFID tag 208 can be applied to a side surface of the reaction plate 100. As set forth in connection with FIG. 1, in various embodiments, the RFID tags can, for example, be adhesively applied to consumables, such as on the reaction plate 100. However, the RFID tags can also be embedded in the body of the consumables, for example during a plastic injection molding or a blow molding manufacturing process. To facilitate a transition from barcodes to RFID, both barcodes (not shown) and RFID tags can be present on consumables consistent with the present teachings, such as the reaction plate 100.


According to various embodiments, the reaction plates contain biological reagents such as nucleic acid materials, primers, and probes, which are used in connection with various biological assays to determine, for example a genetic sequence of a particular sample. In various embodiments, separate RFID tags on the plate are associated with groups of wells within the reaction plate. In other embodiments, an RFID tag is associated with a single well in the reaction plate 100. In other embodiments, a single RFID tag is associated with the entire reaction plate, with the RFID tag containing information regarding each of the wells and the contents and history of the contents of each of the well. In such embodiments, a read/write RFID tag containing a substantial amount of memory can include, for example, identification, supplemental, and/or rights information about the contents of the wells 102 (of FIG. 1).



FIG. 3 illustrates a tube 300 having RFID tags positioned in alternative configurations on the tube 300. The tubes can have a conical internal volume to provide pipette access to small volumes. In various embodiments, the tubes bear both human-readable and/or machine-readable indicia regarding the contents of the tube and/or barcodes in addition to an RFID tag. In various embodiments, the RFID tag is adhesively applied to outer surface 306 of the tube 300 in connection with a label for providing optically-accessible indicia. In various embodiments, RFID tags are provided in the form of printable labels containing an RFID tag integral with the label. The RFID tags can also be affixed to or embedded in a bottom portion of the tube, as shown by RFID tag 304 in FIG. 3. Tubes can store nucleic acids for assays designed for a particular customer or for a particular assay.



FIG. 4 illustrates an embodiment of an empty tube carrier having an RFID positioned at various locations. Tube carriers such as tube carrier 400 are advantageously used to organize and transport a plurality of the tubes 300 containing biological materials. Lid 402 and tube carrier base 404 are used to protect and/or to store the tubes 300 during manufacturing, storage, transportation, and usage phases of the lifecycle of the biological materials supported by the tubes 300. In various embodiments, RFID tags in or on the tubes contain information regarding nucleic acid samples, primers, or probes contained in each of the tubes. In such embodiments information regarding the genetic sequences of the nucleic acids, for example, are stored in the RFID tags. Further, annotated information regarding the biological reagents can be stored in the RFID tags, for example, information regarding results of experiments already performed with the biological reagents.


According to various embodiments, no read/write RFID tag is directly coupled to a particular tube. Rather, the tube bears a simplified RFID tag or optical indicia that provides, for example, row and column information for the tube's position in the tube carrier 400. Then, for example, information regarding the contents of tubes can be stored in a more complex RFID tag that is affixed to or embedded into the tube carrier 400, either at the lid 402 or at the carrier base 404. Alternatively, additional information can be stored on a CDROM or other removable medium and associated with each tube, for example, based on a unique identifier on the RFID tag associated with the tube or tube carrier. The additional information can also be provided in an encrypted on-line database, as further set forth in connection with FIG. 11.


Exemplary RFID tag positions are illustrated in connection with FIG. 4. An RFID tag 408 can be applied to a surface of the lid 402. Alternatively, an RFID tag 406 can be applied to a surface of the tube carrier base 404. Still alternatively, the RFID tag 410 can be embedded into a portion of the tube carrier 400 during a manufacturing process of the tube carrier 400. It is understood that the positions of the RFID tags 406, 408, and 410 are exemplary any not inclusive and that a single or multiple RFID tags can be affixed to or embedded into various portions of the tube carrier 400 without departing from the present teachings.



FIG. 5 illustrates a tube carrier containing a plurality of tubes having associated individual RFID tags and at least one RFID tag on the tube carrier; In various embodiments, as shown in FIG. 5, tube carriers, such as the tube carrier 400 can contain a plurality of the tubes 300. In these various embodiments, information regarding the contents of the tubes, including, for example nucleic acid sequence information, and other annotated information is stored in an RFID tag either affixed to or embedded into each of the tubes 300 or in an RFID tag that is affixed to or embedded into the tube carrier 400.


According to various embodiments, the tube carrier 400 can contain a simplified RFID tag containing only an identifier number, which is cross-referenced to a table that contains information on the contents of particular tubes 300 in the particular tube carrier 400. In various embodiments, the lookup table information is provided on removable, machine-readable media, such as CDROM. In various other embodiments, the lookup table information is provided in the form of a network-accessible, on-line database. In various ones of these embodiments, the lookup table information is encrypted either in an off-line CDROM-type form or in an on-line form.


According to various embodiments, authentication and/or decryption information can be stored in the RFID tag or tags on or in the tubes 300 and/or the tube carrier 400. It is understood that any type of digital authentication and/or cryptography system can be employed to provide access to and decryption for the on-line or off-line data associated with the biological contents of the carriers without departing from the scope of the present teachings.



FIG. 6 illustrates an exemplary embodiment of an SPR array 600 with exemplary RFID tags 604 and 602. The SPR array 600 contains ports 606 that are used to inject a biological reagent into the SPR array. In various embodiments, RFID tags 602 and 604 facilitate the association of information with biological reagents used in connection with the SPR array 600. For example, read/write RFID tag 602 can contain information regarding the biological sample injected into the SPR array. The RFID tag 602 can also be written to by an instrument that is used to detect the results of an assay conducted on the biological reagent that is injected into the SPR array. The RFID tag can further store information regarding locations and patterns of particular nucleic acid spots in the SPR array.


As described above in connection with other consumables, the RFID tags 602 and 604 can be affixed to an outer surface of the SPR array 600 (as shown with RFID tag 602) or embedded in the SPR array during manufacture (as shown with RFID 604). In various embodiments the SPR array is constructed from a standard glass slide which has a layer of gold deposited to an underside surface of the slide, and the RFID tag is adhesively applied to an upper surface 610 of the glass slide.



FIG. 7 illustrates another exemplary embodiment of a reaction plate 700 with at least one associated RFID tag. As described in connection with FIGS. 1 and 2, reaction plates such as the reaction plate 700 can be coupled to an RFID tag to facilitate the association of information with the biological contents of the reaction plate. For example, an RFID tag 702 can be applied to an exterior surface of the reaction plate 700, or an RFID tag 704 can be embedded within a portion of the reaction plate. Any reaction plate with 8, 16, 24, 48, 96 (FIG. 1), 386 (FIG. 7), etc. is contemplated by the present teachings.



FIG. 8 illustrates an exemplary embodiment of a microfluidic card 800 having at least one associated RFID tag. The microfluidic card 800 provides an array containing multiple chambers 814 for testing various biological reagents on many different primer and probe sets thereby, for example, eliminating labor-intensive pipetting steps. In connection with the microfluidic card 800, biological reagents can be injected into the card via inlet ports 810 through channels 812 into the clambers 814.


According to various embodiments, information regarding the contents of the chambers and/or the contents loaded into the card can be provided. Accordingly, RFID tags consistent with the present teachings are affixed to a surface of a portion of the microfluidic card 800 for example on surface 804 as shown in connection with RFID tag 806. The RFID tag 808 is shown as being embedded into a portion of the microfluidic card 800. It is understood that the RFID tag can be affixed to or embedded in other portions of the card, such as the supporting lid portion 802, which has a plurality of apertures, through which the chambers 814 can be observed by an instrument to determine the results of an assay performed in connection with the microfluidic card 800. The RFID tag 806 can include information regarding specific assays preloaded into the microfluidic card. Further, the RFID tag 806 can include information regarding samples injected into the card, which is written to the RFID tag as the samples are being injected into the card.



FIG. 9 illustrates an exemplary embodiment of a microarray cartridge 900 with at least one associated RFID tag. The microarray cartridge 902 is provided to facilitate the protection and loading of a microarray on microarray slide 1000 as illustrated in FIG. 10. In various embodiments, the microarray cartridge 900 is substantially opaque which does not allow for the optical reading of information from the microarray slide 1000. However, consistent with the present teachings, RFID tag information can be read regarding the contents of the microarray slide 1000 even absent an optical path in the microarray cartridge 900. Additionally, information regarding the microarray contained within the microarray cartridge 900 can be stored in RFID tag 904, which can be affixed to an outer surface 902 of the microarray cartridge 900. In various embodiments, the RFID tag 906 can be embedded in a wall portion of the microarray cartridge 900.



FIG. 10 illustrates an exemplary embodiment of the microarray slide 1000 having at least one RFID tag associated with the microarray 1010. RFID tags 1006 and 1008 are shown as alternatively being embedded in substrate 1004 or as being affixed to an outer surface portion of the substrate 1004. It is understood that RFID tags can be positioned in any convenient configuration on the microarray slide 1000, including, for example along an outer periphery of the microarray slide 1000, along an outer periphery of the gasket 1002 positioned around microarray 1010 or on an underside surface of the substrate 1004 without departing from the scope of the present teachings.


According to various embodiments, information can be stored in RFID tags associated with any of the above-described consumables that can be useful, for example, in the transportation of the biological reagents. For example, in connection with the importation and/or exportation of biological reagents, biological reagent content information and country of origin information can be provided consistent with the present teachings. National customs agencies typically require the provision of such country of origin information during import and/or export of various biological reagents. It is understood that the provision of such information by way of an RFID reader interface would drastically expedite the provision to customs authorities of, for example, country of origin information for various biological reagents.


According to various embodiments, Material Safety Data Sheet (MSDS) information can be stored in the RFID tags and read at any time during the lifecycle of the biological reagent while it is contained in or supported by a carrier consistent with the present teachings.


According to various embodiments, the information stored in the RFID tags associated with the biological reagents can include traveler information that is written to the RFID tag at various stages or steps along the course of a biological assay. In various embodiments, genealogy data is read and used during the course of an assay.


According to various embodiments, biological samples or reagents that are provided in the carriers described above are licensed separately from instruments designed to operate on the biological reagents. In various embodiments the instruments are coupled to a network (see e.g. FIG. 11) that allows the instruments to communicate over public and private networks with computer systems that are operated by or on behalf of the producers and/or licensors of the biological reagents. In various embodiments, reagent licenses can provide for the use of licensed biological reagents for a particular biological analysis on only licensed instruments. In various embodiments, instrument licenses can provide for the use of licensed instruments to carry out a particular biological analysis with only licensed reagents. Accordingly, an instrument can authenticate a biological reagent based on, for example, a digital signature contained in the RFID tag associated with a particular consumable, if a particular user has a valid license. IN various embodiments, the RFID tags can also be programmed to provide a one time use such that biological reagents cannot be refilled with for use with the same authentication.


According to various embodiments, when an RFID tag is read by an instrument that has access to a data network that includes a connection to information regarding biological reagent recall information, the instrument can perform a database lookup to determine whether the biological reagent has been subject to a recall. The recall information and an optional last recall check date and/or timestamp can be written to the RFID tag. In various embodiments, a recall database lookup is performed each time before a biological reagent is utilized in an assay or other test such as, for example a clinical diagnostic procedure.


According to various embodiments, external displays are provided to display information regarding the biological reagent contents of a consumable when the biological reagent is inside of an instrument or other container, such as a refrigerator. For example when a microarray is contained within its microarray cartridge, an RFID reader can read the identification information from the microarray and display it on a human readable interface, such as a computer terminal, LCD, or other type of display.



FIG. 11 illustrates an exemplary embodiment of an on-line biological instrument system 1100 consistent with the present teachings. In various embodiments, a general purpose computer 1110 serves a function of controlling an instrument 1106 as it performs operations on biological reagents supported by carriers 1108. RFID tags 1109 that are affixed on or embedded into the carriers 1108 can be read by and/or written to by the RFID reader 1107. In various embodiments, the RFID reader 1107 can read identification information from the RFID tag 1109 to identify the biological reagent being supported by the carrier 1108 at particular points in time. In various embodiments, identifying descriptions, such as the name or work number associated with the biological reagent can be displayed on the monitor of the general purpose computer 1110. In various other embodiments, the identifying descriptions can be provided on a display (not shown) that is externally connected to the instrument 1106.


Via a network connection 1105, the instrument 1106, and/or the general purpose computer 1110 can be connected to a public or private network, such as internet 1104. It is understood that any networking technology can be employed without departing from the present teachings, including wired and wireless networking technologies. It is also understood that, in various embodiments, the network connection associated with the instrument 1106 can emanate from the instrument 1106 as shown or from the general purpose computer 1110.


By employing a network connection, the instrument 1106 and/or its associated general purpose computer 1110 can remotely access databases 1120, 1130, 1140, and 1150 via remote network connections 1103. In various embodiments, information contained in the databases 1120, 1130, 1140, and 1150 can be written to the RFID tag 1209 as set forth below in connection with FIG. 12. In various embodiments, the database 1120 can include identification information. In various embodiments, the database 1130 can include supplemental information, such as annotated information regarding a biological reagent. In various embodiments, the database 1140, can include rights information, which as set forth above can be used to authenticate or validate the biological reagent and/or determine the validity of licenses associated with the biological reagent. In various embodiments, databases 1140 can include information used to check for any product recalls associated with the biological reagent. In various embodiments, the database 1150 can contain information regarding instrument operations. In various embodiments, connections to the databases are encrypted for privacy. In various embodiments, the contents of the databases 1120, 1130, 1140, and 1150 are encrypted for confidentiality and to facilitate access control to the information contained in the databases 1120, 1130, 1140, and 1150.


According to various embodiments, the instrument 1106 includes instrument hardware, instrument firmware, instrument data acquisition and control software, and method or module data. In various embodiments, the instrument hardware includes electronic control and data processing circuitry, such as a microprocessor or microcontroller, memory, and non-volatile storage. In various embodiments, the instrument hardware also includes physical devices to manipulate biological reagents such as robotics and sample pumps. In various embodiments, the instrument firmware includes low-level, computer-readable instructions for carrying out basic operations in connection with the instrument hardware. In various embodiments, the instrument firmware includes microprocessor instructions for initializing operations on a microprocessor in the instrument hardware.


According to various embodiments, the instrument data acquisition and control software is higher-level software that interfaces with the instrument firmware to control the instrument hardware for more specific operations such as operating a charge coupled device (CCD) to acquire visual luminescence information regarding a particular biological analysis. In various embodiments the data acquisition and control software includes a software-implemented state machine providing, for example, the following states: (i) idle; (ii) running; (iii) paused; and (iv) error. In various embodiments, when the state machine is in the idle state, it can receive an instruction from the general purpose machine 1110 to perform a particular data acquisition or instrument control operation. In various embodiments, the general purpose computer 1110 opens a TCP/IP socket connection to the instrument 1106, determines whether the instrument 1106 is in the idle state and then begins transmitting instructions and/or parameters. In various embodiments, an encrypted TCP/IP connection is established, using, for example, the SSH protocol. The instructions and/or parameters can be in the form of ASCII encoded, human readable module and/or method information that defines the behavior of the biological instrument. In various embodiments, the modules and/or methods are stored in the form of ASCII text files. In various embodiments, the general purpose computer 1110 uses the FTP protocol to transfer the ASCII text files to the instrument 1106. In various other embodiments the method and/or module information is stored in and read from the RFID tag 1109. The method and/or module information can be stored in the form of an ASCII text file in the RFID tag 1109, but it is understood that the information can be represented in other data formats without departing from the present teachings. In various embodiments, methods and module information is stored in a relational database, such as those available from the Oracle Corporation of Redwood Shores, Calif.


According to various embodiments, the module, macro, and/or method information includes parameters that can be used by the instrument data acquisition and control software to perform specific data acquisition and instrument control operations. In various embodiments, the method and/or module information contains sequences of operations to be performed by the instrument or control parameters for use in connection with the data acquisition or control software.



FIG. 12 illustrates an exemplary embodiment of an RFID writing apparatus 1200 consistent with the present teachings. RFID carrier 1108 is shown with an associated read/write capable RFID tag 1209. In various embodiments, an RFID reader 1202, having RFID read and write capabilities and antenna 1204, is coupled to the databases 1120, 1130, 1140, and 1150 including identification, supplemental, rights, and instrument operation information respectively. In this configuration any combination of identification, supplemental, rights, and/or instrument operation information can be written to the RFID tag 1209 consistent with the present teachings.



FIG. 13 illustrates an exemplary embodiment of RFID tag tracking systems 1300 consistent with the present teachings. A warehouse 1306 or manufacturing facility includes one or more RFID readers 1308, which can be used to read RFID tags on carriers such as carrier 1108 as the carriers move throughout the warehouse 1306 or manufacturing facility. The RFID readers 1308 can be used for inventory control and to provide real-time product location information. In various embodiments an instrument 1106 can perform operations on a biological reagent being supported by the carrier 1108, while the RFID reader 1308 provides general location information regarding a location of the carrier 1108. Moreover, the external RFID reader 1304 can read from and/or write information into the RFID tag 1109. In various embodiments, external, hand-held RFID readers such as the RFID reader 1304 can be used to write to or read information from the RFID tags 1109. According to various embodiments, obtaining the real-time physical location coordinates of a carrier can be achieved by receiving GPS coordinates from a GPS receiver physically coupled to the carrier.


The section headings used herein are for organizational purposes only and are not to be construed as limiting the subject matter described in any way.


All literature and similar materials cited in this application, including but not limited to, patents, patent applications, articles, books, treatises, and internet web pages, regardless of the format of such literature and similar materials, are expressly incorporated by reference in their entirety for any purpose.


While the present teachings are described in conjunction with various embodiments, it is not intended that the present teachings be limited to such embodiments. On the contrary, the present teachings encompass various alternatives, modifications, and equivalents, as will be appreciated by those of skill in the art.

Claims
  • 1. A system configured for tracking a consumable comprising: an enclosure configured to internally contain a carrier, the carrier comprising an RFID tag and a structure for supporting the consumable, wherein the carrier is at least one of a microarray cartridge, a microfluidics cartridge, a reaction plate, and a carrier comprising polypropylene to be compatible with thermal cyclers; andan RFID reader coupled to the enclosure, the reader configured to at least one of transmit an RFID signal to and receive an RFID signal from the RFID tag, the RFID signal comprising at least one of identification information, traveler information, and rights information.
  • 2. The system of claim 1, further comprising a human readable interface configured to display information regarding the consumable.
  • 3. The system of claim 2, further comprising a processor configured to generate display information in response to the reader receiving RFID signals.
  • 4. The system of claim 1, wherein the system is a refrigerator.
  • 5. The system of claim 1, wherein the carrier is a microarray cartridge.
  • 6. The system of claim 1, wherein the carrier is a microfluidics cartridge.
  • 7. The system of claim 1, wherein the carrier is a reaction plate.
  • 8. The system of claim 7, wherein the carrier comprises polypropylene to be compatible with thermal cyclers.
  • 9. The system of claim 1, further comprising a network connection that is configured to allow the system to communicate over public and private networks.
  • 10. The system of claim 1, further comprising a processor configured to cross-reference the identification information with a lookup table.
  • 11. The system of claim 10, wherein the processor is configured to cross-reference the identification information each time the reader receives the RFID signal.
  • 12. A computer-based method for tracking a consumable comprising: receiving an RFID signal from an RFID tag using an RFID reader, the RFID tag being coupled to a carrier comprising a structure for supporting the consumable, wherein the carrier is at least one of a microarray cartridge, a microfluidics cartridge, a reaction plate, and a carrier comprising polypropylene to be compatible with thermal cyclers;generating a display signal, using a processor coupled to the RFID reader, in response to the RFID signal;sending the display signal to a human readable interface; anddisplaying, using the interface, information regarding the consumable based on the display signal, the information regarding the consumable comprising at least one of identification information, traveler information, and rights information;wherein the processor is coupled to the interface and an enclosure configured to internally contain the carrier.
  • 13. The method of claim 12, further comprising sending the information regarding the consumable through a network to a computer system operated by a producer of the consumable.
  • 14. The method of claim 13, further comprising authenticating a license associated with the consumable using the information regarding the consumable.
  • 15. The method of claim 14, wherein the authenticating of the license is configured to restrict the consumable to a one-time use.
  • 16. The method of claim 14, wherein the authenticating of the license is configured to occur each time the reader receives the RFID signal.
  • 17. The method of claim 12, wherein the carrier is a reaction plate.
  • 18. The method of claim 17, wherein the carrier comprises polypropylene to be compatible with thermal cyclers.
  • 19. The method of claim 12, wherein the carrier is a microarray cartridge.
  • 20. The method of claim 12, wherein the enclosure is a refrigerator.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No. 14/536,451 filed Nov. 7, 2014, which is a continuation of U.S. patent application Ser. No. 14/163,270 filed Jan. 24, 2014, now U.S. Pat. No. 9,019,079, which is a continuation of U.S. patent application Ser. No. 13/689,288 filed Nov. 29, 2012, now U.S. Pat. No. 8,669,849, which is a continuation of U.S. patent application Ser. No. 13/689,267 filed Nov. 29, 2012, now U.S. Pat. No. 8,665,071, which is a continuation of U.S. patent application Ser. No. 13/615,070 filed Sep. 13, 2012, now U.S. Pat. No. 8,669,848, which is a continuation of U.S. patent application Ser. No. 13/253,535 filed Oct. 5, 2011, now U.S. Pat. No. 8,400,304, which is a continuation of U.S. patent application Ser. No. 13/014,366 filed Jan. 26, 2011, now U.S. Pat. No. 8,049,623, which is a continuation of U.S. patent application Ser. No. 12/164,890 filed Jun. 30, 2008, now U.S. Pat. No. 7,880,617, which is a continuation of U.S. patent application Ser. No. 11/647,065 filed Dec. 28, 2006, now U.S. Pat. No. 7,663,487, which is a continuation of U.S. patent application Ser. No. 10/805,093 filed Mar. 19, 2004, now U.S. Pat. No. 7,187,286, all of which are incorporated herein by reference.

US Referenced Citations (243)
Number Name Date Kind
3549406 Ambusk Dec 1970 A
3888759 Elson et al. Jun 1975 A
3960499 White Jun 1976 A
4006069 Hiratsuka et al. Feb 1977 A
4072639 Yamaguchi et al. Feb 1978 A
4094759 Ruhenstroth-Bauer et al. Jun 1978 A
4246092 Mordechai et al. Jun 1981 A
4411490 Daniel Oct 1983 A
4415418 Turre et al. Nov 1983 A
4415428 Nochumson et al. Nov 1983 A
4418098 Maistrovich et al. Nov 1983 A
4548869 Ogawa et al. Oct 1985 A
4548870 Ogawa et al. Oct 1985 A
4569794 Smith et al. Feb 1986 A
4579783 Ogawa et al. Apr 1986 A
4600641 Ogawa et al. Jul 1986 A
4717667 Provochee Jan 1988 A
4718998 Ogawa et al. Jan 1988 A
4737259 Ogawa et al. Apr 1988 A
4908112 Pace Mar 1990 A
4915811 Yamamoto et al. Apr 1990 A
4929972 Anderson et al. May 1990 A
5055517 Shorr et al. Oct 1991 A
5128412 Miyasaka et al. Jul 1992 A
5190632 Fujimiya et al. Mar 1993 A
5212299 Smith May 1993 A
5219923 Shorr Jul 1993 A
5225212 Martin et al. Jul 1993 A
5238651 Chuba Aug 1993 A
5252294 Kroy et al. Oct 1993 A
5306468 Anderson et al. Apr 1994 A
5384028 Ito Jan 1995 A
5395619 Zalipsky Mar 1995 A
5397449 Zewert et al. Mar 1995 A
5455344 Harper et al. Oct 1995 A
5476016 Fedorka-Cray et al. Dec 1995 A
5498324 Yeung et al. Mar 1996 A
5585069 Zanzucchi et al. Dec 1996 A
5641626 Dumais et al. Jun 1997 A
5641634 Mandecki Jun 1997 A
5641400 Kaltenbach et al. Jul 1997 A
5670226 Yoshizawa et al. Sep 1997 A
5672416 Radola et al. Sep 1997 A
5681437 Black et al. Oct 1997 A
5700429 Buhler et al. Dec 1997 A
5741462 Nova et al. Apr 1998 A
5751629 Nova et al. May 1998 A
5764892 Cain et al. Jun 1998 A
5770455 Cargill et al. Jun 1998 A
5779868 Parce et al. Jul 1998 A
5817472 Hardham et al. Oct 1998 A
5840877 Kozulic Nov 1998 A
5851370 Maracas et al. Dec 1998 A
5851488 Saul et al. Dec 1998 A
5859587 Alicot et al. Jan 1999 A
5874214 Nova et al. Feb 1999 A
5882679 Needham Mar 1999 A
5883376 Rosch et al. Mar 1999 A
5885432 Hooper et al. Mar 1999 A
5910287 Cassin et al. Jun 1999 A
5925562 Nova et al. Jul 1999 A
5949049 McCarrick Sep 1999 A
5953682 McCarrick et al. Sep 1999 A
5954931 Maracas et al. Sep 1999 A
5962834 Markman Oct 1999 A
5990238 DiZio et al. Nov 1999 A
5993627 Anderson et al. Nov 1999 A
6013168 Arai Jan 2000 A
6017434 Simpson et al. Jan 2000 A
6017624 Delgado et al. Jan 2000 A
6025129 Nova et al. Feb 2000 A
6027695 Oldenburg et al. Feb 2000 A
6031458 Jacobsen et al. Feb 2000 A
6060022 Pang et al. May 2000 A
6071394 Cheng et al. Jun 2000 A
6085603 Riekkinen Jul 2000 A
6090251 Sundberg et al. Jul 2000 A
6090255 Riley et al. Jul 2000 A
6094137 Rasch et al. Jul 2000 A
6103199 Bjornson et al. Aug 2000 A
6112152 Tuttle Aug 2000 A
6123821 Anderson et al. Sep 2000 A
6132685 Kercso et al. Oct 2000 A
6136173 Anderson et al. Oct 2000 A
6139709 Scott Oct 2000 A
6140146 Brady et al. Oct 2000 A
6147662 Grabau Nov 2000 A
6149058 Albaret Nov 2000 A
6171780 Pham et al. Jan 2001 B1
6187250 Champagne Feb 2001 B1
6201474 Brady et al. Mar 2001 B1
6206292 Robertz et al. Mar 2001 B1
6211781 McDonald Apr 2001 B1
6219137 Vo-Dinh Apr 2001 B1
6245206 Anderson et al. Jun 2001 B1
6251516 Bonner et al. Jun 2001 B1
6258606 Kovacs Jul 2001 B1
6259367 Klein Jul 2001 B1
6277630 Brophy et al. Aug 2001 B1
6278794 Parekh et al. Aug 2001 B1
6280590 Cheng Aug 2001 B1
6297727 Nelson, Jr. Oct 2001 B1
6300141 Segal et al. Oct 2001 B1
6317028 Valiulis Nov 2001 B1
6317208 Hirosawa Nov 2001 B1
6319668 Nova et al. Nov 2001 B1
6329139 Nova et al. Dec 2001 B1
6352854 Nova et al. Mar 2002 B1
6359444 Grimes Mar 2002 B1
6361950 Mandecki Mar 2002 B1
6372428 Nova et al. Apr 2002 B1
6376187 Mandecki Apr 2002 B1
6387623 Mandecki May 2002 B1
6416714 Nova et al. Jul 2002 B1
6417010 Cargil et al. Jul 2002 B1
6429016 McNeil Aug 2002 B1
6454924 Jedrzejewski et al. Sep 2002 B2
6458259 Parce et al. Oct 2002 B1
6483434 UmiKer Nov 2002 B1
6520544 Mitchell et al. Feb 2003 B1
6521111 Amshey Feb 2003 B1
6535129 Petrick Mar 2003 B1
6541211 Patek Apr 2003 B1
6586143 Tan Jul 2003 B1
6637473 Ganz et al. Oct 2003 B2
6649403 McDevitt Nov 2003 B1
6652812 Vartiainen Nov 2003 B1
6670609 Franzen et al. Dec 2003 B2
6677852 Landt Jan 2004 B1
6686158 Mandecki Feb 2004 B2
6699437 Astle Mar 2004 B1
6726820 Frazier Apr 2004 B1
6733728 Mimura et al. May 2004 B1
6734797 Shanks et al. May 2004 B2
6806050 Zhou Oct 2004 B2
6824738 Neeper et al. Nov 2004 B1
6824740 Sheldon, III et al. Nov 2004 B1
6847912 Forster Jan 2005 B2
6858439 Xu Feb 2005 B1
6867048 Kovacs Mar 2005 B2
6881314 Wang et al. Apr 2005 B1
6887362 Huang et al. May 2005 B2
6889468 Bedingham et al. May 2005 B2
6906797 Kao et al. Jun 2005 B1
6917291 Allen Jul 2005 B2
6928353 Finley et al. Aug 2005 B2
6934836 Strand et al. Aug 2005 B2
6935560 Andreasson et al. Aug 2005 B2
6942778 Jalali Sep 2005 B1
6953834 Dejong Oct 2005 B1
6982640 Lindsay et al. Jan 2006 B2
6986836 Panattoni et al. Jan 2006 B2
7053777 Allen May 2006 B2
7061379 Chen et al. Jun 2006 B2
7083106 Albany Aug 2006 B2
7091864 Veitch et al. Aug 2006 B2
7113131 Burke Sep 2006 B2
7118708 Mordekhay Oct 2006 B2
7142987 Eggers Nov 2006 B2
7153403 Alpenfels et al. Dec 2006 B2
7187286 Morris et al. Mar 2007 B2
7298885 Green et al. Nov 2007 B2
7338811 Derhsing Mar 2008 B2
7361260 Amshey et al. Apr 2008 B2
7382258 Oldham et al. Jun 2008 B2
7390458 Burow et al. Jun 2008 B2
7663487 Morris et al. Feb 2010 B2
7880617 Morris et al. Feb 2011 B2
8049623 Morris et al. Nov 2011 B2
8059623 Gandham Nov 2011 B2
8400304 Morris et al. Mar 2013 B2
8665071 Morris et al. Mar 2014 B2
8669848 Morris et al. Mar 2014 B2
8669849 Morris et al. Mar 2014 B2
8890706 Sattler Nov 2014 B2
9019079 Morris et al. Apr 2015 B2
9530035 Morris et al. Dec 2016 B2
9545221 Adhikari Jan 2017 B2
20010008390 Berquist et al. Jul 2001 A1
20010021356 Konrad Sep 2001 A1
20020018733 Kapplein et al. Feb 2002 A1
20020030598 Dombrowski Mar 2002 A1
20020052238 Muroi May 2002 A1
20020076819 Bowman et al. Jun 2002 A1
20020077886 Chung Jun 2002 A1
20020090320 Burow et al. Jul 2002 A1
20020094515 Erlach et al. Jul 2002 A1
20020098472 Erlach Jul 2002 A1
20020098598 Coffen et al. Jul 2002 A1
20020111551 Erlach et al. Aug 2002 A1
20020114739 Weigl et al. Aug 2002 A1
20030017082 Van Deursen et al. Jan 2003 A1
20030058110 Rich Mar 2003 A1
20030072676 Fletcher-Hayes et al. Apr 2003 A1
20030087446 Eggers et al. May 2003 A1
20030087455 Eggers et al. May 2003 A1
20030087955 Miller et al. May 2003 A1
20030124539 Warrington et al. Jul 2003 A1
20030151028 Lawrence et al. Aug 2003 A1
20030183683 Stewart Oct 2003 A1
20030196897 Alpenfels et al. Oct 2003 A1
20030211012 Bergstrom et al. Nov 2003 A1
20030217925 Alpenfels et al. Nov 2003 A1
20030231986 Kocher Dec 2003 A1
20040029109 Lai Feb 2004 A1
20040029310 Bernds et al. Feb 2004 A1
20040094949 Savagian et al. May 2004 A1
20040100380 Lindsay et al. May 2004 A1
20040100415 Veitch et al. May 2004 A1
20040101966 Davis et al. May 2004 A1
20040121432 Klein et al. Jun 2004 A1
20040124437 Doudoumopolous Jul 2004 A1
20040131505 Koeda Jul 2004 A1
20040133092 Kain Jul 2004 A1
20040136873 Meier Jul 2004 A1
20040155754 Fischer et al. Aug 2004 A1
20040161795 Marto Aug 2004 A1
20040172160 O'Dougherty et al. Sep 2004 A1
20040173508 Deursen et al. Sep 2004 A1
20040173781 Lawrence et al. Sep 2004 A1
20040175515 Lawrence et al. Sep 2004 A1
20040175548 Lawrence et al. Sep 2004 A1
20040175550 Lawrence et al. Sep 2004 A1
20040193449 Wildman et al. Sep 2004 A1
20040195102 Panattoni et al. Oct 2004 A1
20040202577 McNeil et al. Oct 2004 A1
20040203047 Caren et al. Oct 2004 A1
20040222297 Dearing et al. Nov 2004 A1
20050159982 Showalter et al. Jul 2005 A1
20050219039 Allen Oct 2005 A1
20050242963 Oldham et al. Nov 2005 A1
20050276728 Muller-Cohn Dec 2005 A1
20060099567 Muller Cohn May 2006 A1
20060173750 Naley Aug 2006 A1
20060190185 Ford et al. Aug 2006 A1
20060199196 O'Banion et al. Sep 2006 A1
20060283945 Excoffier Dec 2006 A1
20080235055 Mattingly et al. Sep 2008 A1
20080237043 Amshey et al. Oct 2008 A1
20090071829 O'Banion et al. Mar 2009 A1
20100262379 Frazier Oct 2010 A1
20100307921 Frazier et al. Dec 2010 A1
20110001609 Oldham et al. Jan 2011 A1
Foreign Referenced Citations (20)
Number Date Country
3032069 Jun 1982 DE
3032071 Jul 1982 DE
3032070 Oct 1982 DE
0376611 Jul 1990 EP
01257255 Oct 1989 JP
H09-111198 Apr 1997 JP
2001-188061 Jul 2001 JP
2003-289566 Oct 2003 JP
2004-061136 Feb 2004 JP
2004-093519 Mar 2004 JP
2004-166555 Jun 2004 JP
2004-246492 Sep 2004 JP
2011-511238 Apr 2011 JP
1996008433 Mar 1996 WO
1996036436 Nov 1996 WO
1998059092 Dec 1998 WO
2001047638 Jul 2001 WO
2005040500 May 2005 WO
2005113147 Dec 2005 WO
2006060125 Jun 2006 WO
Non-Patent Literature Citations (60)
Entry
International Search Report and Written Opinion, international Application No. PCT/US05/40500, dated May 30, 2007.
Pharmaseq, “Illustration of a microtransponder for DNA-probe assays”, http://www.pharmaseq.com/illustration.html, downloaded Sep. 23, 2004.
Sambrook, Joseph., et al., “Introduction of Recombinant Vectors into Mammalian Cells”, Molecular Cloning: a Laboratory Manual, 1989, pp. 16.30-16.60, 2nd Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Service, Robert F., “Radio Tags Speed Compound Synthesis”, Research News, Chemistry, Science, Oct. 27, 1995, p. 577, vol. 270.
Tam, Robert C., et al., “Biological availability and nuclease resistance extend the in vitro activity of a phosphoraothioate-3′hydroxypropylamine oligonucleotide”, Nucleic Acids Research, 1994, pp. 977-986, vol. 22—No. 6, Oxford University Press.
Taylor, Lisa D., et al., “Human immunoglobulin transgenes undergo rearrangement, somatic mutation and class switching in mice that lack endogenous IgM”, International Immunology, 1994, pp. 579-591, vol. 6—No. 4, Oxford University Press.
Ward, Sally E., et al., “Binding activities of a repertoire of single immunoqlobulin variable domains secreted from Escherichia coli”, Letters to Nature, Nature, Oct. 12, 1989, pp. 544-546, vol. 341, Nature Publishing Group.
Winter, Greg, et al., “Humanized antibodies.”, Immunology Today, 1993, pp. 243-246, vol. 14—No. 6, Elsevier Science Publications, Ltd, UK.
Winter, Greg, et al., “Making antibodies by Phage Display Technology.”, Annu. Rev. Immunol, 1994, pp. 433-455, vol. 12, Annual Reviews Inc.
Zebra Technologies, “RFID: The Next Generation of AIDC”, Application White Paper, Aug. 2004, pp. 1-13, Rev. 7, ZIH Corp., Vernon Hills, IL.
Zebra Technologies, “Zebra's RFID Readiness Guide: Complying with RFID Tagging Mandates”, Application White Paper, Jan. 2004, pp. 1-9, ZIH Corp., Vernon Hills, IL.
US 7,165,720, 1/2007, Linton et al. (withdrawn)
Dupont, DuPont Nucrel, Products and Services, 2006, http://www.dupont.com/industrial-polymers/nucrel/.
Lonza, GelBond Film: Casting Agarose Gels on GelBond Film, 2007, Lonza Rockland, Inc. http://www.bioproducts.com/product . . . .
Lonza, GelBond PAG Film, 2007, Lonza Rockland, Inc., http://www.bioproducts.com/product . . . .
Vincogen, “Investors Relationship”, Jan. 28, 2004, Vincogen Corporation, http://www.vincogen.com/Investor/.htm.
VGD LLC, “Membrane Filters”, http://www.voigtglobal.com/membfil.htm.
“New RFID Tag with More Memory”, News, RFID Journal, Aug. 25, 2003, RFID Journal Inc.
SPI Supplies, “Polycarbonate Membrane Filters”, SPI-Pore and Nuclepore brands, 1995-1999, Contracting Structure Probe, Inc., http://www.2spi.com/catalog/spec_prep/filter3.html.
“Report: RFID Labels”, Williams Inference Center, Sep. 28, 2000, vol. 27—No. 15, Longmeadow, MA.
AIM, “Radio Frequency Identification RFID”, A basic primer, The Association of the Automatic Identification and Data Capture Industry, Aug. 23, 2001, pp. 1-17, AIM Inc. Pittsburgh, PA.
Vincogen, “Technology:”, Jan. 28, 2004, Vincogen Corporation, http://www.vincogen.com/technologmyl.htm.
Intermec, “The Write Stuff: Understanding the Value of Read/Write RFID Functionality”, 2003, pp. 1-4, Intermec Technologies Corporation, USA.
Ausubel, Frederick M., et al., “Current Protocols in Molecular Biology”, Table of Contents, 1994-1998, pp. 1-12, vol. 1—supplement 63, John Wiley & Sons, Inc.
Baines, Michael G., et al., “Purification of Immunoglobulin G (IgG)”, Chapter 8, vol. 10: Immunochemical Protocols, Methods in Molecular Biology, 1992, pp. 79-104, The Humana Press, Inc., Totowa, NJ.
Barbas III, Carlos F., et al., “Combinatorial Immunoglobulin Libraries on the Surface of Phage (Phabs): Rapid Selection of Antigen-Specific Fabs”, METHODS: A Companion to Methods in Enzymology, Apr. 1991, pp. 119-124, vol. 2—No. 2, Academic Press, Inc.
Birge, Robert R., “Protein-Based Three Dimensional Memory”, American Scientist, Jul.-Aug. 1994, pp. 348-355, vol. 82.
Birge, Robert R., et al., “Biomolecular Electronics: Protein-Based Associative Processors and Volumetric Memories”, Feature Article, J. Phvs. Chem. B, Sep. 3, 1999, pp. 10746-10766, vol. 103—No. 49, American Chemical Society.
Borrabeck, Carl A.K., “Antibody Engineering”, 1995, Second Edition, Oxford University Press.
Brush, Michael, “Prepare to Cast Off: A Profile of Precast Acrylamide Gels”, Profile, The Scientist, Jul. 20, 1998, 12[15]:18, The Scientist, Inc.
Cooper, Helen M., et al., “Production of Antibodies”, Current Protocols in Immunology, 1995, pp. 2.4.1-2.4.9, Supplement 13, Section II—Unit 2.4, John Wiley & Sons, Inc.
Ecker, David J., et al., “Combinatorial Drug Discovery: Which Methods Will Produce the Greatest Value?”, Review, Biotechnology, Apr. 1995, pp. 351-360, vol. 13.
Supplementary European Search Report and European Search Opinion, European Application No. EP 05 851 446.4, dated Mar. 22, 2012, 8 pages.
Supplementary European Search Report, European Application No. EP 01 93 1132.3, dated Aug. 14, 2008, 3 pages.
Flotte, Terence R., “Prospects for Virus-Based Gene Therapy for Cystic Fibrosis”, Journal of Bioenergetics and Biomembranes, 1993, pp. 37-42, vol. 25.
Fraley, Robert, et al., “New generation liposomes: the engineering of an efficient vehicle for intracellular delivery of nucleic acids”, TIBS, Mar. 1981, pp. 77-80, vol. 6.
Frost, Pam, “Tiny Channels Carved In Plastic Enable Medical Test on a CD”, Ohio State Research News, 2000, The Ohio State University, Columbus, OH, www.osu.edu/units/research.
Goeddel, David V., “Gene Expression Technology”, Table of Contents, Methods in Enxymology, 1990, vol. 185, Academic Press, Inc., San Diego, CA.
Green, Jonathan A., et al., “Production of Polyclonal Antisera”, Chapter 1, Immunochemical Protocols, Methods in Molecular Biology, 1992, pp. 1-5, vol. 10, The Humana Press, Inc., Totowa, NJ.
Green, L.L., et al., “Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs”, article, Nature Genetics, May 1994, pp. 13-21, vol. 7.
Gregoriadis Ph.D., Gregory, “Preparation of Liposomes”, Liposomes Technology, Table of Contents, 1984, vol. 1, CFC Press, Inc., Boca Raton, FL.
Harlow, Ed, et al., “Sampling Serum”, Chapter 5: Immunizations, Antibodies: A Laboratory Manual, 1988, pp. 116-120, 2nd Edition, Cold Spring Harbor Laboratory, USA.
Henke, Cliff, “DNA-chip technologies, Part 1: Research fundamentals and industry catalysts”, IVD Technology Magazine, IVDT Article Index, Sep. 1998.
Henke, Cliff, “DNA-chip technologies Part 2: State-of-the-art and competing technologies”, IVD Technology Magazine, IVDT Article Index, Nov. 1998.
Henke, Cliff, “DNA-chip technologies Part 3: What does the future hold?”, IVD Technology Magazine, IVDT Article Index.
Huse, William D., et al., “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda”, Research Article, Science, Dec. 8, 1989, pp. 1275-1281, vol. 246.
Jellinek, Derek, et al., “Potent 2′-Amino-2′-deoxypyrimidine RNA Inhibitors of Basic Fibroblast Growth Factor”, Biochemistry, 1995, pp. 11363-11372, vol. 34—No. 36, American Chemical Society.
Jolly, Douglas, et al., “Viral vector systems for gene therapy”, Review Article, Cancer Gene Therapy, 1994, pp. 51-64, vol. 1—No. 1, Appleton & Lange.
Kambil, Ajit, “Move Over Barcodes; Consumer-Goods Firms Eye Radio-Frequency ID”, A Deloitte Research Emerging Technologies Brief, 2003, pp. 1-5, Deloitte Consulting.
Kohler, G. et al., Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, Aug. 7, 1975, pp. 495-497, vol. 256.
Kuchinskas, Susan, “IP Addresses for Coke Cans?”, Ecommerce News, Sep. 5, 2003, earthwebnews.com.
Lee, Ph.D., Youbok, “Antenna Circuit Design for RFID Applications”, Microchip AN710, 2003, pp. 1-50, Microchip Technology Inc., USA.
Lin, Yun, et al., “Modified RNA sequence pools for in vitro selection”, Nucleic Acids Research, 1994, pp. 5229-5234, vol. 22—No. 24, Oxford University Press.
Lonberg, Nils, et al., “Antigen-specific human antibodies from mice comprising four distinct genetic modifications”, Letters to Nature, Nature, Apr. 28, 1994, pp. 856-859, vol. 368.
Michael, Sharon I., et al., “Binding-incompetent Adenovirus Facilitates Molecular Conjugate-mediated Gene Transfer by the Receptor-mediated Endocytosis Pathway”, The Journal of Biological Chemistry, Apr. 1993, pp. 6866-6869, vol. 268—No. 10, The American Society for Biochemistry and Molecular Biology, Inc., USA.
Moran, Edmund J., et al., “Radio Frequency Tag Encoded Combinatorial Library Method for the Discovery of Tripeptide-Substituted Cinnamic Acid Inhibitors of the Protein Tyrosine Phosphatase PTP1B”, Communications to the Editor, J. Am. Chem. Soc., 1995, pp. 10787-10788, vol. 117, American Chemical Society.
Morishita, Ryuichi, et al., “Novel and Effective Gene Transfer Technique for Study of Vascular Renin Anglotensin System”, J. Clin. Invest., Jun. 1993, pp. 2580-2585, vol. 91, The American Society for Clinical Investigation, Inc.
Pagratis, Nikos C., et al., “Potent 2′-amino-, and 2′-fluoro-2′-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor”, Research, Nature Biotechnology, Jan. 1997, pp. 68-73, vol. 15.
“International Search Report”, International Application No. PCT/US01/40489, dated Jul. 6, 2001.
“International Preliminary Report on Patentability and Written Opinion”, International Application No. PCT/US05/40500, dated Jul. 19, 2007.
Related Publications (1)
Number Date Country
20170087555 A1 Mar 2017 US
Divisions (1)
Number Date Country
Parent 14536451 Nov 2014 US
Child 15375953 US
Continuations (9)
Number Date Country
Parent 14163270 Jan 2014 US
Child 14536451 US
Parent 13689288 Nov 2012 US
Child 14163270 US
Parent 13689267 Nov 2012 US
Child 13689288 US
Parent 13615070 Sep 2012 US
Child 13689267 US
Parent 13253535 Oct 2011 US
Child 13615070 US
Parent 13014366 Jan 2011 US
Child 13253535 US
Parent 12164890 Jun 2008 US
Child 13014366 US
Parent 11647065 Dec 2006 US
Child 12164890 US
Parent 10805093 Mar 2004 US
Child 11647065 US